Joseph Elich
Director, Process Development & CMC Prime Medicine
Joe Elich is Director of Process Development & CMC at Prime Medicine, where he leads development strategies to advance next-generation gene editing therapeutics. With prior experience at Moderna, Genentech, and Pulmatrix, Joe brings deep expertise across mRNA process development, high-throughput technology development, analytical characterization, and scalable manufacturing. He holds both a B.S. in Biological Engineering and an M.Eng in Chemical Engineering from Cornell University.
Seminars
Thursday 1st October 2026
Enabling Scalable RNA-Based Delivery for Next-Generation Gene Editing Therapies
3:30 pm
- Exploring key CMC and process development considerations for delivering RNAbased gene editing systems across in vivo (e.g. LNP) and ex vivo manufacturing workflows
- Addressing challenges in achieving consistent editing efficiency while maintaining product quality, potency, and safety across different delivery modalities and target tissues
- Discussing how platform-based development strategies can support scalability, tech transfer, and clinical translation of next-generation genetic medicines
